Brief: Biora Therapeutics To Submit Updated IND Application For BT-600

Biora Therapeutics

24/10/2023 12:36

Oct 24 (Reuters) - Biora Therapeutics Inc  BIOR.O :
    * BIORA THERAPEUTICS TO SUBMIT UPDATED IND APPLICATION FOR
BT-600
    * BIORA THERAPEUTICS INC - BIORA ANTICIPATES REMAINING ON
TRACK
WITH ITS PHASE 1 CLINICAL TRIAL EXECUTION TIMELINE
    * BIORA THERAPEUTICS INC - UPDATE TO INCLUDE SUPPLEMENTAL
INFORMATION AND ALLOW ADDITIONAL TIME TO COMPLETE REGULATORY
REVIEW
    * BIORA THERAPEUTICS INC - UPDATE TO INCLUDE SUPPLEMENTAL
INFORMATION AND ALLOW ADDITIONAL TIME TO COMPLETE REGULATORY
REVIEW
    * BIORA THERAPEUTICS: PLANS TO ADDRESS FDA'S QUESTIONS AND
SUBMIT
UPDATED FILING, POTENTIALLY AS EARLY AS THIS WEEK
    * BIORA THERAPEUTICS: CONTINUE TO HAVE A CONSTRUCTIVE
EXCHANGE
WITH FDA, ANTICIPATE REMAINING ON TRACK WITH PREVIOUSLY
COMMUNICATED EXECUTION TIMELINE

Source text for Eikon:  ID:nGNX9X8XZ3 
Further company coverage:  BIOR.O 

 ((Reuters.Briefs@thomsonreuters.com))